Thomas de Vlaam supports founders in biotech. He built companies at Flagship Pioneering and founded Amylon Therapeutics, now a partner at Pillar VC.
What Thomas can write
Pillar VC writes $25K to $10M checks, larger than 1% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Pillar VC.Career
- ProQR Therapeutics · head of CNS innovation
- Amylon Therapeutics · founder and CEO
- Flagship Pioneering
- Pillar VC · PartnerNow
- ProQR Therapeutics
- Amylon Therapeutics · CEO
- Flagship · Associate
- Pillar VC · PrincipalNow
Companies founded
Investments named in public bios
Focus
Education
Also at Pillar VC
Partners like Thomas
At firms with a similar stage, sector and check size.
Alert me when Pillar VC is active
One email when Thomas's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Thomas de Vlaam?
Thomas de Vlaam supports founders in biotech. He built companies at Flagship Pioneering and founded Amylon Therapeutics, now a partner at Pillar VC.
How much does Thomas de Vlaam invest?
Thomas de Vlaam invests through Pillar VC, which writes checks of $25K to $10M at seed, series a.
How do I pitch Thomas de Vlaam?
Email [email protected], the firm's inbox for founders, and name Thomas in the subject. A warm intro from a founder Pillar VC backed works better.
What did Thomas de Vlaam do before Pillar VC?
head of CNS innovation at ProQR Therapeutics; founder and CEO at Amylon Therapeutics; Flagship Pioneering; ProQR Therapeutics; CEO at Amylon Therapeutics; Associate at Flagship.
Last updated 2026-10-15. Is this you? Ask for a correction.